These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1084 related articles for article (PubMed ID: 16050785)
1. The role of cetuximab in the treatment of squamous cell cancer of the head and neck. Burtness B Expert Opin Biol Ther; 2005 Aug; 5(8):1085-93. PubMed ID: 16050785 [TBL] [Abstract][Full Text] [Related]
3. IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer. Herbst RS; Hong WK Semin Oncol; 2002 Oct; 29(5 Suppl 14):18-30. PubMed ID: 12422310 [TBL] [Abstract][Full Text] [Related]
4. IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer. Herbst RS; Kim ES; Harari PM Expert Opin Biol Ther; 2001 Jul; 1(4):719-32. PubMed ID: 11727507 [TBL] [Abstract][Full Text] [Related]
5. Cetuximab: from bench to bedside. Vincenzi B; Zoccoli A; Pantano F; Venditti O; Galluzzo S Curr Cancer Drug Targets; 2010 Feb; 10(1):80-95. PubMed ID: 20088790 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers. Herbst RS; Langer CJ Semin Oncol; 2002 Feb; 29(1 Suppl 4):27-36. PubMed ID: 11894011 [TBL] [Abstract][Full Text] [Related]
7. Epidermal Growth Factor Receptor Inhibition in Squamous Cell Carcinoma of the Head and Neck. Machiels JP; Schmitz S Hematol Oncol Clin North Am; 2015 Dec; 29(6):1011-32. PubMed ID: 26568545 [TBL] [Abstract][Full Text] [Related]
8. EGFR-targeting monoclonal antibodies in head and neck cancer. Astsaturov I; Cohen RB; Harari PM Curr Cancer Drug Targets; 2006 Dec; 6(8):691-710. PubMed ID: 17168674 [TBL] [Abstract][Full Text] [Related]
9. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. Bonner JA; Harari PM; Giralt J; Azarnia N; Shin DM; Cohen RB; Jones CU; Sur R; Raben D; Jassem J; Ove R; Kies MS; Baselga J; Youssoufian H; Amellal N; Rowinsky EK; Ang KK N Engl J Med; 2006 Feb; 354(6):567-78. PubMed ID: 16467544 [TBL] [Abstract][Full Text] [Related]
10. New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN). Agulnik M Med Oncol; 2012 Dec; 29(4):2481-91. PubMed ID: 22252310 [TBL] [Abstract][Full Text] [Related]
11. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives. Bozec A; Peyrade F; Milano G Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267 [TBL] [Abstract][Full Text] [Related]
12. Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer. Blick SK; Scott LJ Drugs; 2007; 67(17):2585-607. PubMed ID: 18034592 [TBL] [Abstract][Full Text] [Related]
13. Cetuximab in the treatment of squamous cell carcinoma of the head and neck. Specenier P; Vermorken JB Expert Rev Anticancer Ther; 2011 Apr; 11(4):511-24. PubMed ID: 21504318 [TBL] [Abstract][Full Text] [Related]
14. Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers. Vokes EE; Chu E Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):15-25. PubMed ID: 16736979 [TBL] [Abstract][Full Text] [Related]
15. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Zimmermann M; Zouhair A; Azria D; Ozsahin M Radiat Oncol; 2006 May; 1():11. PubMed ID: 16722544 [TBL] [Abstract][Full Text] [Related]
16. Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines. De Pauw I; Wouters A; Van den Bossche J; Deschoolmeester V; Baysal H; Pauwels P; Peeters M; Vermorken JB; Lardon F Cancer Biother Radiopharm; 2017 Sep; 32(7):229-238. PubMed ID: 28910149 [TBL] [Abstract][Full Text] [Related]
17. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck. Mehra R; Cohen RB; Burtness BA Clin Adv Hematol Oncol; 2008 Oct; 6(10):742-50. PubMed ID: 18997665 [TBL] [Abstract][Full Text] [Related]
18. Cetuximab in squamous cell carcinoma of the head and neck. Hitt R; MartÃn P; Hidalgo M Future Oncol; 2006 Aug; 2(4):449-57. PubMed ID: 16922611 [TBL] [Abstract][Full Text] [Related]
19. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC). Cohen RB Cancer Treat Rev; 2014 May; 40(4):567-77. PubMed ID: 24216225 [TBL] [Abstract][Full Text] [Related]
20. The role of inhibitors of the epidermal growth factor in management of head and neck cancer. Brockstein B; Lacouture M; Agulnik M J Natl Compr Canc Netw; 2008 Aug; 6(7):696-706. PubMed ID: 18691458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]